News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Clinical trials news

Show

From To
Starting treatment
European activists claim Pfizer's CCR5 antagonist trial unnecessarily putting most vulnerable at risk; US activists disagree

European HIV treatment activists, the European AIDS Treatment Group (EATG), are demanding that a worldwide trial of Pfizer’s investigational CCR5 antagonist, maraviroc (UK-427,857) in HIV-positive

Published
19 April 2005
By
Edwin J. Bernard
HATIP #38, 22nd December 2004

Combination of antibiotics as effective and safe as co-trimoxazole at preventing infections, but too expensive to use where needed? http://www.aidsmap.com/en/news/3806F479-2DCA-4701-8A30-32C79DEF1E46.asp?hp=1 A combination of the antibiotics atovaquone and

Published
22 December 2004
From
HIV & AIDS treatment in practice
Health services and systems
Trizivir approved in Europe

The three-in-one pill anti-HIV medication Trizivir has been approved for use in Europe, the European Medicines Agency announced yesterday. The drug is likely to be

Published
05 March 2001
By
Keith Alcorn
Drug interactions and pharmacokinetics
What to do with nelfinavir?

Two studies presented on Monday at the 40th ICAAC raised some difficult questions about the role of nelfinavir in antiretroviral therapy. Nelfinavir is one of

Published
05 March 2001
By
Keith Alcorn
Clinical trials
Triple PI salvage therapy

Salvage therapy with three protease inhibitors alongside nucleoside analogues or the NNRTI efavirenz is being explored by clinicians at the Royal Free Hospital in London. They

Published
05 March 2001
By
Keith Alcorn
Clinical trials
European activists and drug authority agree on need for single early access system

Europe should have a single system for making drugs available to people who need them before they have completed phase III trials, according to European

Published
05 March 2001
By
Keith Alcorn
← Prev1...2122232425Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.